4.6 Article

The Roles of the Epithelial-Mesenchymal Transition Marker PRRX1 and miR-146b-5p in Papillary Thyroid Carcinoma Progression

Journal

AMERICAN JOURNAL OF PATHOLOGY
Volume 184, Issue 8, Pages 2342-2354

Publisher

ELSEVIER SCIENCE INC
DOI: 10.1016/j.ajpath.2014.04.011

Keywords

-

Categories

Funding

  1. NIH [R01-CA121115]
  2. American Cancer Society
  3. Department of Pathology
  4. NIH Cancer Center Support Grant [P30-CA014520-39]

Ask authors/readers for more resources

Thyroid carcinoma is the most common endocrine malignancy, and papillary thyroid carcinoma represents the most common thyroid cancer. Papillary thyroid carcinomas that invade locally or metastasize are associated with a poor prognosis. We found that, during epithelial-mesenchymal transition (EMT) induced by transforming growth factor-beta 1 (TGF-beta 1), papillary thyroid carcinoma cells acquired increased cancer stem cell-Like features and the transcription factor paired-related homeobox protein 1 (PRRX1; alias PRX-1), a newly identified EMT inducer, was markedly up-regulated. miR-146b-5p was also transiently up-regulated during EMT, and in siRNA experiments miR-146b-5p had an inhibitory role on cell proliferation and invasion during TGF-beta 1-induced EMT. We conclude that papillary thyroid carcinoma tumor cells exhibit increased cancer stem cell-Like features during TGF-beta 1-induced EMT, that miR-146b-5p has a rote in cell proliferation and invasion, and that PRRX1 plays an important role in papillary thyroid carcinoma EMT and disease progression.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available